· 2013

A PROSPECTIVE, RANDOMIZED TRIAL OF AUTOLOGOUS BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY IN MULTIPLE MYELOMA

M Ichel A Ttal, J Ean, A.A. D uuml nne, Arie S Toppa et al.

2,166citations
2013year

Short summary

High-dose therapy combined with autologous bone marrow transplantation (ABMT) significantly improved response rates, event-free survival (EFS), and overall survival (OS) in previously untreated multiple myeloma patients compared to conventional chemotherapy.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Hematology

HematologyMedicine